Modulight Biotherapeutics
United States
- Boston, Massachusetts
- 13/11/2025
- Seed
- $12,000,000
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
- Industry Biotechnology Research
- Website https://www.modulight.bio/
- LinkedIn https://www.linkedin.com/company/modulight-bio/
Related People
Yotam EldarFounder
United States -
Boston, Massachusetts
Experienced leader of operational and technology teams, with a passion for solving complex multidisciplinary problems in a data-driven and results-oriented manner, to achieve a solid and positive impact in the world.
Long track record of excellence across several fields and industries - from leading complex special operations and projects, through medical practice, to biotech innovation.
Currently Yotam is focused on building a transformative solution for intractable neurological conditions, utilizing his deep technical understanding, creativity, leadership and networking skills to create a truly meaningful, positive change for patients.
Kin Health | $9,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Hellbender Inc. | $12,500,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
viktor.com | $75,000,000 | (May 20, 2026)
Brami Inc. | $33,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)